WOLFF STEFANI (Senior VP of Strategy and Ops) sold 22.4% of their position (5.50K shares) of PRINCIPIA BIOPHARMA INC. on the open market
Open‑market sale worth $334.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/17/2020ACC: 0001209191-20-037486
Officer· Senior VP of Strategy and Ops
Since Sep 2018
-5.50K
Net shares
Net seller
$334.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
5.50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−400.00
Price / share
$59.89
Trade value
$23.96K
% of position
1.6%
6/15/2020
24.60K→24.20K
Common Stock
Direct
Shares
−5K
Price / share
$60.81
Trade value
$304.29K
% of position
20.7%
6/15/2020
24.20K→19.20K
Common Stock
Direct
Shares
−100.00
Price / share
$61.37
Trade value
$6.14K
% of position
0.5%
6/15/2020
19.20K→19.10K
Total
Net shares
−5.50K
Net value
-$334.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2020 | S · Sale | −400.00 | $59.89 | $23.96K | 1.6% | 24.60K | 24.20K |
| Common Stock Direct | 6/15/2020 | S · Sale | −5K | $60.81 | $304.29K | 20.7% | 24.20K | 19.20K |
| Common Stock Direct | 6/15/2020 | S · Sale | −100.00 | $61.37 | $6.14K | 0.5% | 19.20K | 19.10K |
| Total | −5.50K | -$334.38K | ||||||
Derivative Transactions0
No derivative transactions reported